
Strategic Research on the Molecular Diagnostics Industry in China
Lan Xie, Ran Liu, Juan Feng, Wanli Xing, Jing Cheng
Strategic Study of CAE ›› 2017, Vol. 19 ›› Issue (2) : 29-36.
Strategic Research on the Molecular Diagnostics Industry in China
Molecular diagnostics is an important part of personalized medicine and has become the main driving force of the in vitro diagnostics industry. In recent years, China's molecular diagnostics industry has been growing rapidly, despite its small size. Based on literature research, expert interviews, and field investigation, we performed an intensive market analysis of the current situation of the domestic molecular diagnostics industry. The aim of this study is to explore the characteristics of the domestic molecular diagnostics industry; identify opportunities and challenges in innovation, industrial transformation, and related policies and regulations; and propose approaches to overcome existing constraints under the current administrative system. This analysis is of great significance for promoting the development of China’s molecular diagnostics industry.
molecular diagnostics / in vitro diagnostics / market analysis / policies and regulations / biochip
[1] |
吕建新. 分子诊断学在检验医学中的应用前景 [J]. 中华检验医学杂志, 2005, 28(2): 137–139.
|
[2] |
2020年全球体外诊断(IVD)市场将达747亿美元 [J]. 中国医药技术经济与管理, 2014(3): 16.
|
[3] |
伊遥. 分子诊断产品扩容前景可期 [N]. 医药经济报, 2011-06-17(A02).
|
[4] |
王悦. 中外品牌争夺中国200亿体外诊断市场 [N]. 第一财经日报, 2015-06-09.
|
[5] |
王亮. 分子诊断行业专题报告:探寻生命原始奥秘, 分子诊断亟待爆发 [R]. 广州:广证恒生证券研究所有限公司, 2016.
|
[6] |
Huggett J F, Cowen S, Foy C A. Considerations for digital PCR as an accurate molecular diagnostic tool [J]. Clinical Chemistry, 2015, 61(1): 79–88.
|
[7] |
Harris T D, Buzby P R, Babcock H, et al. Single-molecule DNA se-quencing of a viral genome [J]. Science, 2008, 320(5872): 106–109.
|
[8] |
杨阔, 张小琴, 宋永, 等. 分子成像技术及应用 [J]. 河南教育学院学报, 2010, 19(4): 17–20.
|
[9] |
Su X, Cheng K, Jeon J, et al. Comparison of two site-specifically 18F-labeled affibodies for PET imaging of EGFR positive tumors [J]. Molecular Pharmaceutics, 2014, 11(11): 3947–3956.
|
[10] |
府伟灵, 罗阳. 分子诊断在医院感染中的应用 [J]. 中华医院感染学杂志, 2009, 19(14): 1771–1775.
|
[11] |
王懿. 生物芯片市场—2016版 [R]. 上海:麦姆斯咨询,2016.
|
[12] |
搜狐网 . 预计2020年生物芯片行业市场将达到9亿美元 [EB/OL].(2015-06-26) [2016-11-15]. http://mt.sohu.com/20150626/n415693087.shtml.
|
[13] |
基因谷 . 基因检测公司估值排行榜 [EB/OL]. (2016-11-24) [2016-12-05]. http://www.genegood.com/a/view/667.html.
|
[14] |
唐学良. 内外企竞相入场分子诊断 [N]. 医药经济报, 2012-11-26 (A03).
|
[15] |
张旭. 中国IVD 产业喜忧参半 [N]. 中国医药报, 2007-11-14.
|
[16] |
李耀华, 张世庆. 体外诊断试剂行业发展回顾与展望 [J]. 检验医学与临床, 2017, 14 (2): 299–301.
|
[17] |
长江证券 . IVD 行业深度报告: 崛起中的朝阳行业 [EB/OL]. (2015-07-29) [2016-11-15]. http://www.bioon.com/trends/news/613619_2.shtml.
|
/
〈 |
|
〉 |